Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

(MedPage Today) — FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial.
In its premarket approval application for the Ventura Interatrial Shunt…

Source link : https://www.medpagetoday.com/cardiology/chf/118788

Author :

Publish date : 2025-12-02 17:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

Polypharmacy Is a Real Issue. Dismantling Public Health Won’t Fix It.

Delaying Hep B Vaccine in Infants Carries Significant Risks, Report Warns

Related Posts

Long-Acting HIV Drug Switch Shows No Major Metabolic Impact

Rapamycin can add years to your life, or none at all – it’s a lottery

Parental Obesity Before Pregnancy Linked to Kids’ Chronic Liver Disease Risk

States Sue Trump Admin Over Changes to Childhood Vaccine Recommendations

FDA Approves a Balloon That Patients Swallow to Lose Weight

More Residency Slots Needed in Rural Areas, Lawmakers and Health Experts Say

Long-Acting HIV Drug Switch Shows No Major Metabolic Impact

Rapamycin can add years to your life, or none at all – it’s a lottery

Parental Obesity Before Pregnancy Linked to Kids’ Chronic Liver Disease Risk

States Sue Trump Admin Over Changes to Childhood Vaccine Recommendations

FDA Approves a Balloon That Patients Swallow to Lose Weight

More Residency Slots Needed in Rural Areas, Lawmakers and Health Experts Say

As Measles Cases Pass 1,000 for the Year, Experts Urge Vaccination

Semaglutide Not Linked to Depression Symptoms in People With HIV

Categories

Archives